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Abstract
The primary purpose of this paper is to investigate the mechanics of Aβ protein aggregation
within the brain through mathematical modeling and simulation. Aggregation of Aβ is the
cause of plaques within the brain of Alzheimer’s Disease suﬀerers. Because the pathways of
aggregation from monomer to oligomer to polymer are numerous and complex, we have had
to simplify our model to a limited number of species. Of great concern, too, is the process
by which Aβ can form as “oﬀ-pathway” species, which is when Aβ reacts with fatty acid
micelles. It is this species of Aβ, which due to its toxicity to neurons, that is now believed
to cause Alzheimer’s Disease.

Although the precise mechanism of Aβ aggregation continues to be heavily debated,
evidence suggests a rate-limiting mechanism. Thus we will use Mass Action Kinetics to
write a system of diﬀerential equations for the purpose of simulating aggregation of the Aβ
protein in its diﬀerent forms. We will analyze the stability of the system under diﬀerent
reaction rate regimes, as well as the system’s preferences for particular equilibrium states.
Finally, we will examine the thermodynamics of the system.
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Chapter 1

Introduction
1.1

Motivation

According to the Fisher Center for Alzheimer’s Research, 30 million people live with
Alzheimer’s Disease (AD) worldwide, and the number is expected to reach 60 million people
by 2030 [1]. Alzheimers Disease can occur in people as young as their early 40’s (Early
Onset), but these cases represent only 5% of the total. Most AD cases occur in people in
their mid-60’s and on, with approximately 10% of the population at risk of contracting the
disease in that age group. By some estimates, by the time a person reaches their mid-80’s,
there is a 50% chance of having AD. Thus have improvements in health and longevity been
a mixed blessing. According to the Alzheimer’s Association, the average duration of the
disease is 7 years, and once contracted progressively worsens, ultimately resulting in death.
There is currently no cure.
The Alzheimer’s Association recently reported that the cost of care for people with AD
in the US will consume 25% of Medicare spending by the middle of the century. In 2010
alone, the total, direct cost of AD care in the US was $157 billion, or approximately $50,000
per patient. These ﬁgures, while of concern on their own, don’t count the indirect burden
of AD care exacted upon loved ones and caregivers. For those who cannot aﬀord nursing
home care, looking after a family member with AD can be an all-consuming job. Therefore,
the number of people aﬀected by AD is much larger than the 30 million who actually have
the disease. In many developed countries, with the aging of populations, these social and
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ﬁnancial costs will only continue to increase.
Thus, from both a public health and a ﬁscal health perspective, Alzheimer’s Disease is a
major challenge worldwide. The need for research is therefore vitally important. While we
are enabling people to live longer, this increased longevity comes at a great cost in terms of
caring for a signiﬁcant proportion of the elderly population who are incapacitated, not to
mention the diminished quality of life of those suﬀering from AD. It is these concerns that
have motivated our research.

1.2

History of AD

The identiﬁcation of the causes of dementia is credited to Alois Alzheimer. In 1907,
while performing an autopsy on a woman who had died from a progressive behavioral and
cognitive disorder, Alzheimer noted the presence of two pathologies: neuroﬁbrillary tangles
and neuritic plaques [2]. Neurons are cells that transmit nerve impulses, or information,
throughout the body, and the tangles were essentially deformed neurons. The plaques were
extra-cellular deposits found throughout the brain. Subsequent research down the years
has shown that these tangles are related to the protein tau and the neuritic plaques are
aggregations of the amyloid-β peptide (Aβ) [2]. In our research, we will be modeling the
latter pathology: the formation of Aβ plaques.

1.3

The Biophysics of AD

At the outset it should be noted that much of what we “know” about the role of Aβ
or the causes of AD are heavily debated. In fact, scientists have long been puzzled by the
weak link between the amount of Aβ deposition and the degree of dementia, not to mention
the uncertainty as to which form of Aβ causes AD [3]. AD suﬀerers all have the plaques,
however not all people with the plaques necessarily had AD. The process of aggregation from
monomer to oligomer is also poorly understood [4]. This lack of understanding is due in part
to two major problems with AD research: ﬁrst, early diagnosis at this point is inexact and
unreliable, and secondly, measuring the amount of Aβ plaque deposition occurs only post
mortem [3]. Thus, accurately tracking the progression of the disease in humans is virtually
impossible at this time. With that said, the following is a brief outline of what can best be
described as the consensus view.
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Alzheimer’s Disease is one in a class of protein folding disorders called amyloidosis [1].
Amyloid Precursor Protein (APP) is produced in large quantities in the brain, and is believed
to play an important role in healthy cell functioning. APP is broken down into monomers
(single units) of amino acids by the action of beta and gamma secretase enzymes. It is
these amino acids that can aggregate to form Aβ peptides (or oligomers), which are strings
of these amino acids. These peptides form extracellular deposits, or plaques, which are
believed to be toxic to neurons. Aβ40 is the most abundant, but it is Aβ42 , which due to its
hydrophobic and ﬁbrillogenic nature, that is responsible for plaque deposition in AD brains.
Recent evidence, however, seems to implicate an intermediate form of Aβ, which is soluble,
as the cause of AD rather than the plaques themselves. It is this “oﬀ-pathway” aggregation
of the soluble form of Aβ that is now thought to be the neurotoxic agent[3].
Thus, aggregation of Aβ, in some form, is believed to constitute the central process in
the AD pathology. Brains of AD patients contain large amounts of plaques that are mainly
comprised of insoluble Aβ ﬁbril deposits.

Figure 1.1: Plaque Deposits in AD Brain.
Monomeric Aβ peptides (Aβ40 and Aβ42 ) spontaneously undergo self-assembly towards
large ﬁbrils in a nucleation dependent manner. Although the precise mechanism of nucleation
continues to be heavily debated, substantial evidence suggests a rate-limiting mechanism for
the formation of nucleus or nuclei [5; 6; 7; 8; 9]. The dynamics associated with reactions
leading up to nucleation is critical for aggregation. Energetically, the pre-nucleation phase
is nebulous with monomers and oligomers (dimers, trimers etc.) being in dynamic ﬂux involving stochastic interactions [10; 11; 12]. Intrinsic disorder and amphipathic nature of
monomeric Aβ also facilitate signiﬁcant phase transitions and heterogeneous interactions
during nucleation, making the process particularly sensitive to environmental factors such as
pH, ionic strength, temperature and other interacting partners [13; 15; 16; 17; 18]. This is sig10
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niﬁcant because smaller, soluble aggregates have emerged as the primary neurotoxic agents
responsible for memory loss in AD [19; 20; 21; 22]. Furthermore, it is clear that oligomers
may not be obligatory intermediates to ﬁbril formation, and that the oligomers can also be
populated along alternate pathways of aggregation (oﬀ-pathways) [23; 24; 25; 26; 27; 28].
As previously mentioned, oﬀ-pathway oligomers may diﬀer from those formed along the onpathway resulting in multiple conformational variants with distinct biochemical and cellular
properties. Given the conformational diversity among oligomers, it is imperative to determine the factors that aﬀect dynamics involved in their formation to establish a framework
of molecular mechanisms that better deﬁnes amyloid progression.

Some of such biologically signiﬁcant interacting partners that could aﬀect Aβ pre-nucleation
dynamics are anionic surfactants such as fatty acids and lipids [29; 30; 31; 32; 33; 34; 35].
Interfaces of lipids and fatty acids are of profound interest in physiological contexts as they
are abundant in both cerebral vasculature and CSF [36; 37]. Amphipathic Aβ peptide is
known to have strong aﬃnity for membranes and hence, these interactions may aﬀect early
steps of aggregation. Several reports also show the eﬀects of phospholipids on Aβ aggregation [38; 39; 40]. Similarly, polyunsaturated (PUFAs) as well as saturated fatty acids are also
known to have a signiﬁcant eﬀect on AD brain [41; 42]. In previous publications, our collaborators have also reported the generation of 4-5mers and 12-24mers from lauric acid interfaces
along a non-ﬁbril formation pathway [18]. More importantly, using carbon chain lengths of
C9-C12 fatty acids, we established that below (non-micellar), near (pseudo-micellar) and
above (micellar) their critical micelle concentrations, they generate Aβ oligomers or ﬁbrils
via distinct pathways [18].

There are 3 main sections to this report. In the ﬁrst section, we examine a reduced-order
4 species model. Using Mass Action Kinetics, we formulate a system of diﬀerential equations
that model the chemical reactions between these four species. We then examine the stability
of the system to verify the validity of the model and the appropriateness of our parameters.
We also study the evolution of the model and its equilibria under various rate regimes. Our
collaborators at Virginia Commonwealth University have created a much larger and more
11
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complicated version of our system. Our approach has been to simplify this system so that
we can focus on a limited number of parameters that determine the pathways of Aβ aggregation. Other recent work along the lines of mathematical modeling of Aβ aggregation
includes that done by Murphy and Knowles. What sets our work apart from these is our
analysis of stability, modeling of species evolution over time, and our use of a game theoretic
approach to competition between species.

In the second part, we will look at a six species model where we will again analyze the
stability and numerical results. By adding two more species to the model, we add another
path leading to oﬀ-pathway aggregation, thus adding more complexity to the system while
keeping its essential simplicity. In the third part, we will analyze the thermodynamics of the
system.

What follows is an investigation into mathematically modeling the aggregation process of
Aβ. The major obstacle to investigating AD is the lack of understanding of the progression
of the disease. Therefore, comparing our model to actual data is impossible at this point.
Thus we have had to content ourselves with a purely mathematical analysis. Although we
are not presuming to recommend therapies or direct courses of action to cure Alzheimer’s,
the hope is to gain a greater understanding of what could be happening inside the brain
of an AD suﬀerer. Our models are simpliﬁed versions consisting of 4 and then 6 species
of Aβ with the objective of understanding the dynamics of the system on a rudimentary
level. Even with just 6 species, however, there are inﬁnitely many rate regimes that we
could investigate, most of which would be physically meaningless. Thus, we have not made
an exhaustive sweep of all parameter values, but have chosen to experiment with physically
meaningful rate regimes about which we have varied our key parameters. The goal is to
gain a greater understanding of how to mathematically model Aβ aggregation and hopefully
make a contribution to solving what is becoming a serious health care crisis.
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Chapter 2

Four Species Model
2.1

The Model

We examine the sets of on- and oﬀ-pathway reactions shown below. The model system
is as follows:
k1+

A1 + L  A1
k1−
k2+

n · A 1  An
k2−

n·

A1

k3+

 An
k3−

We use the Law of Mass Action Kinetics to formulate our system of diﬀerential equations. For example, if we take the second chemical reaction that describes the aggregation
of molecules of the species A1 into an n-mer, An ,
k2+

n · A 1  An
k2−

and consider just the forward reaction,
k+

2
n · A1 
An

the left side are the reactants, and the right side are the products, with k2+ being the reaction
rate constant. In a reaction, the stoichiometric coeﬃcients, in this case n, become exponents
[44]. If we add the backward reaction, this coupled system would be expressed as:
dA1
= nk2− An − nk2+ An1
dt
dAn
= −k2− An + k2+ An1
dt

13
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In similar fashion, the entire system of the above reactions would be expressed as,
dA1
(2.3)
= nk2− An − nk2+ An1 + k1− A1 − k1+ A1 L
dt
dA1
− 
+
(2.4)
= nk3− An − nk3+ An
1 − k 1 A1 + k 1 A1 L
dt
dAn
(2.5)
= −k2− An + k2+ An1
dt
dAn
(2.6)
= −k3− An + k3+ An
1
dt
that are better suited for analysis in non-dimensional form. If we chose the characteristic
concentration and time as A0 (the equilibrium concentration of monomers) and

1
,
k1−

respec-

tively, then the dimensionless variables can be deﬁned as,
A1 
A
An 
A
B1 =
; B1 = 1 ; Bn =
; Bn = n
A0
A0
A0
A0
−
+ n−1
+
k
k A
k L
k−
k + An−1
α1 = 2− ; α2 = 2 −0 ; α3 = 1− ; β1 = 3− ; β2 = 3 −0 ;
(2.7)
k1
k1
k1
k1
k1
the corresponding dimensionless diﬀerential equations of which can now can be written as,
dB1
(2.8)
= nα1 Bn − nα2 B1n + B1 − α3 B1
ds
dB1
(2.9)
= nβ1 Bn − nβ2 B1n + α3 B1 − B1
ds
dBn
(2.10)
= α2 B1n − α1 Bn
ds

dBn
(2.11)
= β2 B1n − β1 Bn
ds

Figure 2.1: Schematic of the system with backward and forward rates.

2.2

Equilibrium points

In the equations (2.3)-(2.6), if we consider the limit (k1+ , k1− , L) → (0, 0, 0), then the
oﬀ-pathway dynamics is turned oﬀ, leaving only the reaction below.
k2+

n · A1  An
k2−

14
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However, the on-pathway cannot be switched oﬀ and always persists. In this case the equi
 +
1/n 
k
. In the more general case of
librium solution is given by the pair A1,e , k2− A1,e
2


 , B , B
equations (2.8)-(2.11), the equilibrium points, Be = B1,e , B1,e
n,e
n,e can be obtained
by the vanishing of the equations 2.8-2.11. Solving for these four simultaneous equations,
we obtain the following relations, in terms of the equilibrium concentration B1,e :

Bn,e =

α2 n
β2 α3n n


B1,e ; B1,e
= α3 B1,e ; Bn,e
=
B .
α1
β1 1,e

(2.12)

The substricpt e indicates that these species are in equilibrium.

2.3

Linear Stability Analysis

When formulating a system of diﬀerential equations, it’s important to analyze the stability of the system. Speciﬁcally, we are interested in the eﬀect upon the system of small
changes in initial conditions. Do these changes have a negligible eﬀect on the solutions, or
do they result in dramatic changes? The method used to determine this is linear stability
analysis. The idea is to perturb the system with a small change  > 0 to the initial conditions and then linearize the perturbed system at our equilibrium point to determine the
trajectories at that point. The method involves writing the Jacobian matrix of the system
evaluated at the ﬁxed, or equilibrium, point. The eigenvalues of the Jacobian are the solutions of the linearized system at this point, those being exponentials whose powers are the
eigenvalues. Negative eigenvalues mean that the perturbation decays to zero, or converges
to the equilibrium point, while positive eigenvalues mean that the system moves inﬁnitely
away from the equilibrium point over time.
There are three general classiﬁcations of ﬁxed points for a system of diﬀerential equations:
a ﬁxed point is asymptotically stable if all of the eigenvalues are negative, unstable if just one
of the eigenvalues are positive, and neutrally stable if the eigenvalues are complex with real
parts less than or equal to zero. When the eigenvalues all have the same sign, the ﬁxed point
is a node which can be stable or unstable depending on the sign of the eigenvalues. When
the eigenvalues diﬀer in sign, the ﬁxed point is a saddle point which is unstable. Complex
eigenvalues just add oscillations and are called spiral points, which again can be stable or
15
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unstable depending upon the sign of the real part. In the case when there are zero real parts
(with none being positive), the ﬁxed point is a center, and is considered neutrally stable:
small perturbations neither decay to the equilibrium point nor do they diverge inﬁnitely
away from the equilibrium point.
To study the stability of the four species, we linearly perturb the system which is mathematically represented by

B1 = B1,e + X1

(2.13)


B1 = B1,e
+ Y1

(2.14)

Bn = Bn,e + Xn

(2.15)


+ Yn
Bn = Bn,e

(2.16)
(2.17)

then the linearized set of diﬀerential equations for the perturbations, at o() becomes
dX1
=
dt
dY1
=
dt
dXn
=
dt
dYn
=
dt
which can be expressed in

⎛
⎜
⎜
⎜
⎜
B=⎜
⎜
⎜
⎝

−n2 α

n−1
X1 + Y1 − α 3 X1
nα1 Xn − n2 α2 B1,e

(2.18)

n−1
Y1 − Y1 + α 3 X1
nβ1 Yn − n2 β2 α3n−1 B1,e

(2.19)

n−1
X1 − α 1 Xn
nα2 B1,e

(2.20)

n−1
Y1 − β1 Yn
β2 α3n−1 B1,e

(2.21)

operator form with the perturbation matrix B given by

n−1
2 B1,e

− α3

α3

nα1

1
−n2 β

n−1 n−1
B1,e
2 α3

−1

0

n−1
nα2 B1,e

0

−α1

0

n−1
β2 α3n−1 B1,e

0

⎞
0

⎟
⎟
nβ1 ⎟
⎟
⎟
⎟
0 ⎟
⎠
−β1

The matrix B is the Jacobian which is evaluated at the equilibrium point given by 2.12.
The stability of the equilibrium is found from computing the eigenvalues, λi (i = 1, 2, 3, 4)
of the matrix B. This is best done numerically. In the ﬁgures below we discuss the results
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of the computations. In particular, the term α3 is varied throughout the analysis since it
captures a signiﬁcant dynamical feature of this problem; the switching from on-pathway to
oﬀ-pathway. Over all, we choose the following ranges for our parameters: 0 ≤ α3 ≤ 2 for
i = 1, 2; 2 ≤ n ≤ 20; and 10−3 ≤ αi , βi ≤ 2 × 103 for i = 1, 2. We begin with the base case
deﬁned by the choice α1 = β1 = 0.001, α2 = β2 = 1, n = 4 and B1 = 1 and then study the
sensitivity of the system and our results to each of the parameters.

Figure 2.2: The eigenvalues of matrix B as a function of α3 . Case (a) shows the switching
event at a critical value of α3 while panel (b) shows the eigenvalues to the on- and oﬀpathways.

The ﬁgure 2.3 shows a signiﬁcant event in the dynamics of this system. As α3 is increased
from zero, the real part of the eigenvalues λi are all negative, indicating that the equilibria
are stable. When α3 < 1.0, we see that λ2 > λ1 . However, when α3 > 1.0, λ2 < λ1 indicating
an exchange in the magnitude of the stability. For α3 > 1.0, it appears that the species B1
become more stable than B1 , indicating a transcritical-like bifurcation at α3 = 1.01 . The
switching of stabilites is clear from the meaning of α3 which encompasses the ratio of the
forward to backward rate constants for this reaction and also contains the concentration of
the micelles which enhances the formation of the primed-species. The ﬁgure 2.3(b) shows
the rate of reformation of the species Bn and Bn which is seen to be a bit slower than the
monomeric species. The ﬁgure 2.3(a) shows a second switching at around α3 = 1.87 beyond which could be indicative of the eﬀect of the strong nonlinearity of the system, which
needs to be experimentally veriﬁed. However, this could be a mathematical artifact and may
1

We note that the traditional deﬁnition of trans-critical bifurcation involves a stable equilibrium and one
unstable equilibrium which exchange stabilities.
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Figure 2.3: The eigenvalues of matrix B as a function of α3 . Case (a) shows the switching
event at a critical value of α3 while panel (b) shows the eigenvalues to the on- and oﬀpathways.
point to the invalidity of α3 > 1.87. The latter case can be helpful in selecting appropriate,
physically meaningful rate constants which remains a signiﬁcant confounding aspect of this
approach.

Next we varied the backward and forward parameters, αi , βi for i = 1, 2 (see ﬁgure 2.4).
When we increase the backward rates from our Base Case, the model exhibits an increase
in stability as represented by the magnitude of the eigenvalues (left image in ﬁgure 2.4).
Again, however, λ3 is a marginal case being just barely in negative territory. When we
increase forward rates (α2 , β2 ) λ1 and λ2 become more negative while λ3 and λ4 become less
so (right image in ﬁgure 2.4). Thus, when backward and forward rates are more in line with
each other, the model exhibits greater stability.
The eﬀect of n on the system was also explored (for 2 ≤ n ≤ 20) and seen to result in
some very signiﬁcant changes to the stability of the system (see ﬁgure 2.5). In particular,
the eigenvalues λ1 and λ2 showed dramatic changes as n varies. As n increases, we see
an increase in the magnitude of stability of both λ1 and λ2 , however, λ3 and λ4 exhibit a
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switching in stability as n increases, with n = 4 being the most stable environment for this
parameter, albeit marginally so. Both λ3 and λ4 are just barely in negative territory.
Overall, the stability of our model was very sensitive to the rate constants. The Base
Case model was seen to be asymptotically stable, but marginally so (λ3 and λ4 ). In other
words, perturbations to initial conditions decay but only gradually. At worst, when the
forward rates α2 and β2 are increased for instance, the model was neutrally stable. The
non-linearity of the system and the number of dimensions made analyzing the stability of
the system diﬃcult. Perhaps the use of a non-linear method to analyze this problem in the
future may bear fruit.

2.4

Numerical Results

The system of equations (2.3)-(2.6) were solved using the Matlab ode45 function. A
sample solution is shown in Fig. 2.6 corresponding to initial conditions: B1 (0) = 1, B1 (0) =
Bn (0) = Bn (0) = 0, α1 = β1 = .001, α2 = β2 = 1 and n = 4.
At equilibrium, equations (2.8)-(2.11) vanish, and (2.10) and (2.11) imply that,
n
α2 B1,e
= α1 Bn,e




n
β2 B1,e
= β1 Bn,e

(2.22)
(2.23)

 . Thus,
Substituting (2.22) and (2.23) into equations (2.8) and (2.9) we have α3 B1,e = B1,e
 , and using this in (2.22) and (2.23) means that B

if α3 = 1, we have B1,e = B1,e
n,e = Bn,e .

As can be seen from ﬁgure 2.6, at the limit it must be that we have
∗n
B1,e
∗
= B1,e
α1
where ∗ indicates both on- and oﬀ-pathway species. The high forward rates of the Base Case
∗
Bn,e
=

strongly favor formation of n species, and as the model evolves it will seek equality of species
size in spite of the initial “head start” that both on- and oﬀ-pathway monomers have. At
 =B

α3 = 1 the system is such that B1,e = B1,e
n,e = Bn,e , or the Nash equilibrium.

2.4.1

Nash Equilibrium

Figure 2.7 shows the time evolution of species for the Base Case for diﬀerent values of α3 .
The horizontal line α3 = 1 entirely determines on- or oﬀ-pathway species formation over the
long term for the Base Case. The yellow portion is where B1 < B1 and Bn > Bn . For α3 > 1
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we do see dominance of Bn over Bn for a time, but over the long term, both oﬀ-pathway
species eventually dominate. The second ﬁgure shows the same graph, zoomed-in over the
time period t = 3000 − 4000. For α3 slightly above 1, we continue to see a thin band of
yellow, however at α3 = 1, over time we do have equality of all species. Interestingly, we
were unable to force B1 > B1 and Bn < Bn , which would seem to be a result of not having
a direct pathway between B1 and Bn ; a limitation of the model as constructed.
If viewed as a “competition” in the vernacular of Game Theory, who are the players,
what are the rules, and what are the payoﬀs? In the case of our model, the “players” are the
competing on- and oﬀ-pathways, the rules of the game are the reaction rate constants, and
the payoﬀs are the diﬀerent equilibrium states. In the case of a competition with diﬀerent
strategic options, the Nash equilibrium is the particular set of strategies that the players
would adopt regardless of how the competition behaved. In the biophysical context, it is the
set of parameters from which neither competing species would deviate if view as sentient
“competitors”. For our model, then the equilibrium Be |α3 =1 = BN ash,e is nothing but the
Nash equilibrium of the system given by


α2 n β2 n
BN ash,e := B1,e , B1,e , B1,e , B1,e
α1
β1
(see ﬁgure 2.6 for an example of such an equilibrium). This equilibrium exists only at α3 = 1
which has been seen to have special signiﬁcance in terms of the stability of the system. It
follows that when α3 > 1, then the oﬀ-pathway species dominate creating more equilibrium
 and B  , and for α < 1, on-pathway dominates resulting in greater
concentrations of B1,e
3
n,e

production of B1,e and Bn,e .
We deﬁne k + = k1+ L and k − = k1− so that the former leads to oﬀ-pathway and the
latter to on-pathway. The table below points to a sample case of the various strategies in
the competition between the two pathways with the pay-oﬀ for each “strategy” given by the
equilibrium concentrations.
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OFF-PATHWAY
= 10
k+ = 1
Equality
on-pathway
oﬀ-pathway
Equality
oﬀ-pathway oﬀ-pathway
k+

ONPATHWAY

k − = 10
k− = 1
k − = 0.1

k + = 0.1
on-pathway
on-pathway
Equality

Table 2.1: A sample game-theoretical payoﬀ matrix to depict the on- and oﬀ-pathway competition.

Figure 2.4: Eigenvalues as a function of backward rates (ﬁrst frame) and forward rates
(second frame).
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Figure 2.5: Eigenvalues as n is varied.

Figure 2.6: Solution of Model with B1 (0) = 1, B1 (0) = Bn (0) = Bn (0) = 0, α1 = β1 = .001,
α2 = β2 = 1 and n = 4.
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Figure 2.7: Time evolution of the Base Case model as α3 varies. The red region is strictly
on-pathway, blue is strictly oﬀ-pathway, and yellow is where B1 < B1 and Bn > Bn or
mixed on-/oﬀ-pathway. Thus there are 2 possible equilibrium states, where a mixed state
can persist in the short run. The second graph is a zoomed-in version of the ﬁrst, showing
the persistence of yellow over long periods of time for α3 close to 1.
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Chapter 3

Six Species Model
3.1

The Model

We wanted to increase the complexity of our system by increasing the number of species
to six. The idea behind increasing the model size was to add another pathway between
on- and oﬀ-pathway species. In this model, oligomers can react with the fatty acid L to
create oﬀ-pathway oligomers. The system of chemical reactions in our model consist of the
following,
k1+

A1 + L  A1
k1−
k2+

n · A 1  An
k2−
k3+

n · A1  An
k3−
k4+

An + nL  An
k4−
+

k5
m
· A n  Am
n
k5−
+

k6
m
· An  Am
n
k6−

As with the 4 Species Model, the non-prime species, A1 , An , and Am represent on-pathway
Aβ monomers and oligomers; whereas the prime species, A1 , An , and Am , are the oﬀ-pathway
species which are created through a reaction with the fatty acid micelles, L. For each species,
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n = 4 and m = 20 unless otherwise speciﬁed; which denotes the order of oligomer.

Using the Law of Mass Action Kinetics, we formulate the system of diﬀerential equations
as follows.
dA1

(3.1)
= nk2− An − nk2+ An1 + k1− A1 − k1+ A1 L
dt

dA1


(3.2)
= nk3− An − nk3+ A1n + k1+ A1 L − k1− A1
dt
m
dAn
m
m
(3.3)
= k2+ An1 + k5− Am + k4− An − k2− An − k4+ An Ln − k5+ Ann
dt
n
n

m
dAn
m
m


(3.4)
= k3+ A1n + k4+ An Ln + k6− Am − k3− An − k6+ An n − k4− An
dt
n
n
m
dAm
(3.5)
= k5+ Ann − k5− Am
dt
m
dAm
(3.6)
= k6+ An n − k6− Am
dt
This system is then put into non-dimensional form. We let A0 be the characteristic concentration of monomers and
B1 =

1
k1−

be time, and deﬁne the dimensionless species as follows






A1
An
Am 
A
A
A


; Bn =
; Bm =
; B1 = 1 ; Bn = n ; Bm = m
A0
A0
A0
A0
A0
A0

The reaction constants are deﬁned as follows:

α1 =

k2−
; α2
k1−

β1 =

=

k2+ An−1
0
; α3
k1−

k3−
; β2
k1−

=

=

k1+ L
; α4
k1−

k3+ An−1
0
; β3
k1−

=

=

k4+ Ln
; α5
k1−

m −1
k5+ A0n
k1−

=

; β4 =

k5−
; α6
k1−

k4−
; β5
k1−

m −1

=

=

k6+ A0n
k1−

k6−
k1−

Note that both α3 and α4 have a factor L which is responsible for oﬀ-pathway aggregation.
These will be the bridge variables between on- and oﬀ-pathway species in the analysis which
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follows. The dimensionless system is
dB1

= nα1 Bn − nα2 B1n + B1 − α3 B1
ds

dB1



= nβ1 Bn − nβ2 B1n + α3 B1 − B1
ds
m
dBn
m
m
= α2 B1n − α1 Bn + α5 Bm + β4 Bn − α4 Bn − β3 Bnn
ds
n
n

m
dBn
m
m


− α6 Bn n − β4 Bn
= β2 B1n − β1 Bn + α4 Bn + β5 Bm
ds
n
n
m
dBm
= β3 Bnn − α5 Bm
ds

m
dBm

= α6 Bn n − β5 Bm
ds

(3.7)
(3.8)
(3.9)
(3.10)
(3.11)
(3.12)

Figure 3.1: Schematic of System with forward and backward rates.
Below is a table of the non-dimensional reaction variables that we will be referring to
in our work. Reaction variables between on- and oﬀ-pathway species will be referred to as
“bridge” variables.

On/Oﬀ Pathway Reaction Rate Variables
Forward
Backward
On-Pathway
α2
β3
α1
α5
Oﬀ-Pathway
β2
α6
β1
β5
Bridge
α3
α4
β4
Table 3.1: Table of reaction rates between species

Throughout this part of our work, we will primarily be analyzing two models which will
be referred to as the Base Model and Model 2. Our choices of the parameters in these two
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models are guided by prior work with our collaborators in the belief that they capture the
essential dynamics of the system, without loss of generality. In our Base Model, we set
all forward rates and bridge rates equal to 1 and all backward rates to .001, as previous
mathematical models and experimental data have indicated [43]. In the context of our
model, a forward rate is deﬁned as one that converts a smaller molecular structure into a
larger structure, and backward being the reverse process. In Model 2, we set all forward and
backward rates equal. We used Matlab’s ode 45 for our numerical solutions.

3.2

Equilibrium Points

In order to study the stability of the system we have had to rely on experimental data
to determine our rate constants which in turn determine our equilibrium, or ﬁxed point,
concentration levels [43]. With the Four Species Model, we were able to analytically solve
for the equilibrium concentration sizes by simultaneously solving the system of ODEs in
terms of a single species. Because the Six Species model is so highly interdependent, we
were unable to use this approach. The presence of two bridge reactions between on- and oﬀpathway meant that each species was dependent on two other species in a circular fashion.
Given the above discussion, our ﬁrst problem was how to determine the equilibrium points
for the system, with the stipulation that all species sizes be greater than zero. Equilibria
where any species size is zero would be of little interest in the context of our problem.
Because our system is non-linear and 6 dimensional, there are many possible ﬁxed points.
We weren’t interested in classifying all of these points, but only those corresponding to our
models.
In general, equilibrium for our model is the set of points that would make (3.7)-(3.12)
vanish for a given set of parameter values. We knew from the numerical solutions of the
model that the system appeared to settle at equilibrium, or more accurately, that each
species exhibited asymptotic behavior. In the absence of being able to solve our system, we
wanted to approximate a limiting value for each species. The non-analytical analog of this
would be where the change in concentration size for each species gets reasonably close to
zero as t → ∞, knowing that absolute zero would most likely be unachievable due in part
to numerical error. One solution to this problem would be to just use very large values of t
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and take the ending concentration levels as our equilibrium points. The necessity of running
a large number of simulations under diﬀerent rate environments, however, meant that we
needed to limit how big t could be.
To solve the problem of having to limit computation time, we ran both models through a
code that would identify the time T when the change in all species sizes was less than 0.1%
of the previous level using time increments of 5. For instance, we computed the change in
concentrations sizes for t = 0 : 5, t = 0 : 10, etc. This would be a proxy for solving our system
for 0, and the concentration levels at time T would be our equilibrium concentration sizes.
As it turns out, concentration sizes continue to ﬂuctuate over time for both models, but in all
cases these ﬂuctuations were within 0.1% of previous levels for t > T , which we considered
acceptable. To conﬁrm our equilibrium values, we ran the results through Matlab’s fsolve as
will be discussed shortly. In the following simulations we set initial conditions to be B1 = 1
with all other species at 0. Below are the graphs of the numerical solutions of the Base
Model and Model 2.
As can be seen from the graphs in ﬁgure 3.2, as time increases the concentration levels
exhibit asymptotic behavior and equilibrium appears to be achieved. We found, however,
that the “look” of the graph was deceptive. Because the absolute size of the concentration
 were so small, the ﬂuctuations weren’t showing up on the solution graphs.
of Bm and Bm

Figure 3.3 shows graphs of the Base Model and Model 2 showing the percentage change in
concentration sizes as a function of time using representative species. Bm is shown as that
is one of the species that tended to have greater ﬂuctuations over time.
It’s clear from 3.3 that there continues to be relatively large percent changes in concentration levels in the Base Model while the concentration levels in Model 2 “settle” down more
quickly. As our working deﬁnition of equilibrium, we therefore wanted to see the absolute
percentage change in concentration of any species to be no greater than 0.1% over a period
of 5 units of time. As it turned out, in order to achieve our deﬁnition of equilibrium for the
Base model, we needed to use a time span of t = 0 : 2200, whereas for Model 2 we needed a
time span of just t = 0 : 20. We had therefore found that the type of rate regime used has
a dramatic eﬀect on the time it takes for the system to reach equilibrium. Figure 3.4 is a
graph of the Base Case model with t = 0 : 2200, and a zoomed in concentration size window.
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Figure 3.2: Solutions of the Base Model and Model 2.
While it appears that it takes longer for B1 , B1 , Bn , and Bn to settle, it is in fact Bm
 (in green) that continue to grow until our deﬁnition of equilibrium is achieved at
and Bm

t = 2200. To conﬁrm our hypothesis, we ran the model through Matlab’s numerical nonlinear system solver, fsolve. As our initial “guess”, we used the ﬁnal concentration size at
t = 2200 and with just 1 iteration, fsolve returned an equilibrium value for each species
that was within 2% of our guess. By increasing the time span to 2500, we were able to get
this diﬀerence under 1%. We considered these to be reasonably accurate equilibrium values
for our Base Case model with which to work. Below are plots of the percentage change of
 over diﬀerent timespans. B  continues to grow slowly as B ﬂuctuates over
B1 and Bm
1
m
 is approximately at 0% change while B continues
t = 350 − 450. In the second plot, Bm
1

ﬂuctuating.
Under the Model 2 regime shown below, equilibrium is achieved more quickly. Using a
time span of just t = 0 : 20, and taking the ending concentration sizes as an initial guess,
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Figure 3.3: Absolute percentage change of the concentration of B1 and Bm as a function of
time over identical time spans. Model 2 achieves equilibrium more quickly.
fsolve returned a value that was at worst, 0.08% diﬀerent from our equilibrium value. The
diﬀerence in time it takes to achieve equilibrium seems to be a function of the ratio of
backward to forward rates: the closer that ratio is to 1, the more quickly the system reaches
equilibrium. We ran a power regression of the data and found that the time to equilibrium
is T E ≈ 25r−.615 (ﬁgure 3.6 and table) where r is the ratio of backward to forward rates.
Intuitively speaking, the direction that has a much smaller reaction rate will tend to become
overwhelmed until that species has a critical concentration mass where, despite the lower
reaction rate, it’s greater relative concentration size will “push back”. This will create a
cycle of over-shoot that will take longer to dissipate. Interestingly, in the case of Model 2
 that has the greater ﬂuctuations while
as our deﬁnition of equilibrium is achieved it is Bm

B1 is more stable (see ﬁgure 3.7), the opposite of the Base Model. It would appear that
increasing backward rates, while enabling the model to settle to equilibrium more quickly
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Figure 3.4: Solution of the System (Base Case) with t = 0 : 2200 and zoomed in concentration
 .
size. Note the slow but continued growth of Bm and Bm

 over diﬀerent timespans for the
Figure 3.5: Plots showing percentage change of B1 and Bm
Base Model.

does increase ﬂuctuations in the concentration size of n and m species relative to monomers.

As increasing backward rates from the Base Model to Model 2 had greatly reduced the
time it took to achieve equilibrium, it made sense to look at a regime where backward
rates are greater than forward rates. While not necessarily physically meaningful in the
context of our problem, for comparisons sake, we wanted to know the time horizon over
which equilibrium was achieved. For this model, we ﬁrst set forward rates to be 0.01, and
then 0.001, with backward rates equal to 1 in both cases. In this scenario, the model did not
settle down to our deﬁnition of equilibrium even over a time span of t = 0 : 5000. In fact,
 became greater over time.
large (percentage-wise) ﬂuctuations in the concentration of Bm

Figure 3.8 is the graph of this simulation. Note that the scale of the graph is ±150%.
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Time to Equilibrium
Backward/Forward Ratio Equilibrium Time
0.0001
5,190
0.001
2,200
0.01
595
0.1
105
1
20
Table 3.2: Time to equilibrium as a function of the ratio of backward to forward rates.

Figure 3.6: Equilibrium time as a function of the ratio of backward to forward rates.
Due to low forward rates, the concentration size of B1 stays high and stable throughout,
 . We analyzed the concenbut there are periodic, large percentage changes in the size of Bm
 over this period and their growth and decline patterns
tration pattern of both B1 and Bm

are a mirror image of each other: periods of increase in B1 were accompanied by declines in
 . Because the relative concentration sizes are so diﬀerent, percentage-wise changes in B
Bm
1

were on a much smaller scale, as can be seen from the graph.
From our equilibrium analysis of these three models we found when the ratio of backward
to forward rates is close to 1, the model settles at equilibrium more quickly than when there
are large diﬀerences in the magnitude of backward and forward rates. Also, the higher we
put backward rates the more volatility in the concentration size of n and m species relative
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 under Model 2 conditions, after equilibrium
Figure 3.7: Fluctuations in the size of B1 and Bm
is achieved.

to monomers, whereas higher forward rates had the opposite eﬀect.
Below is a table of the analysis of equilibrium.
Analysis of Equilibrium
Base Model Model 2
Time T to Equilibrium
T = 2200
T = 20
Max. Diﬀerence Model/fsolve
1.7%
0.08%

High Backward
-

Table 3.3: Time to equilibrium of the Base Model and Model 2 versus fsolve.
We also looked at both models with various sizes of oligomers by varying n and m. In
both cases, increasing n and m had the eﬀect of increasing the time it took for each model
to reach equilibrium. Below is a table of results. It could be that the higher the power of the
non-linear terms, the greater the potential for over- and under-shoot as the model evolves
over time, thus taking longer to achieve equilibrium.
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Figure 3.8: Percentage change in concentration of B1 and B’m with high backward rates.
Time to Equilibrium
Oligomer Size Base Model Model 2
n = 2, m = 10
780
25
n = 4, m = 20
2,200
20
n = 6, m = 30
3,650
30
n = 8, m = 40
4,020
35
Table 3.4: Table of time to equilibrium values as n and m are varied.

3.3

Linear Stability Analysis

Like the 4 species model, we linearize the dimensionless system as shown below.
B1 = B1,e + X1

(3.13)


B1 = B1,e
+ Y1

(3.14)

Bn = Bn,e + Xn

(3.15)


+ Yn
Bn = Bn,e

(3.16)

Bm = Bm,e + Xm

(3.17)



Bm
= Bm,e
+ Ym

(3.18)
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Here, for instance, B1,e is the equilibrium concentration of the species B1 , and X1 is the
perturbation. For our equilibrium concentrations, we used the values derived in the previous
section.
We substitute these values into equations (3.7)-(3.12) and keep only the linear terms of
order . The linearized system is
dX1
n−1
X1 + Y 1 − α 3 X1
(3.19)
= nα1 Xn − n2 α2 B1,e
ds
dY1

Y 1 + α 3 X1 − Y 1
(3.20)
= nβ1 Yn − n2 β2 B1,e
ds
m
dXn
m
m
−1
n−1
n
X1 − α1 Xn + α5 Xm + β4 Yn − α4 nXn − ( )2 β3 Bn,e
xn
(3.21)
= nα2 B1,e
ds
n
n
 n−1
m
m
dYn
 m
−1
n
− β1 Yn + nα4 Xn + β5 Ym − ( )2 α6 Bn,e
Yn − β4 Yn
(3.22)
= β2 B1,e
ds
n
n
m
dXm
m
−1
n
Xn − α 5 Xm
(3.23)
= β3 Bn,e
ds
n
m
dYm
 m
−1
n
Yn − β5 Ym
(3.24)
= α6 Bn,e
ds
n
Which is then put into operator matrix form using the appropriate rate constants and equilibrium values found in the previous section
⎛
⎜
⎜
⎜
⎜
B=⎜
⎜
⎜
⎜
⎝

n−1
−(n2 α2 B1,e
+ α3 )

1

nα1

α3

n−1
−(n2 β2 B1,e
+ 1)

0

n−1
nα2 B1,e

0

0

n−1
nβ2 B1,e

−(α1 + α4 +



m −1
n

m2
β3 Bn,e
n

α4

0

0

m −1
m
β Bn
n 3 n,e

0

0

0

)

0

0

0

nβ1

0

0

β4
−(β1 +

m
−1
n

m2
α6 Bn,e
n

+ β4 )

m
α
n 5

0

0

m
β
n 5

0

−α5

0

−1
m
α B n
n 6 n,e

0

−β5

m

We then compute the eigenvalues of B, the Jacobian, which is shown in the table below.
Because we were not able to determine equilibrium for the high backward rate regime, we
have excluded it from the stability analysis. Notice that all of the eigenvalues are negative
with the exception of λ5 = 0 for the Base Model and λ2 = 0 for Model 2.

Base Model
Model 2

Eigenvalues of Base Model and Model 2
λ1
λ2
λ3
λ4
λ5
−2.0320 -2.0020 -0.0320
-0.0028
0.0000
−4.0149 0.0000 −2.0149 −2.0000 −1.0000

Table 3.5: Eigenvalues of the Base Model and Model 2.
Below are plots of the Base Model λ5 as a function of both α3 and α4 .
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Figure 3.9: The ﬁrst ﬁgure is λ5 as a function of α3 and the second graph is λ5 as a function
of α4 . Note that the scale is 10−16 .
λ5 is zero out to the 15th decimal place. In the case of Model 2, λ2 was on a similar
scale. λ5 is ﬂuctuating between ±2.5 × 10−16 , depending on parameter values, or eﬀectively
zero if we make allowance for round-oﬀ error in the numerics. This would mean that neither
model is asymptotically stable, but rather neutrally stable. While perturbations of initial
conditions won’t blow up, nor will they decay to equilibrium.
As the rate regime had a signiﬁcant impact on time to equilibrium, so too did it impact
stability. We therefore ran simulations of each model while varying the rate regime. Of key
interest was the eﬀect of the bridge parameters, α3 and α4 , and their eﬀect on the stability
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Figure 3.10: λi as a function of α3 and α4 .
of each model. Figures 3.10 and 3.11 are contour plots of the eigenvalues of the Base Model
and Model 2 with 0 ≤ α3 , α4 ≤ 2. We incremented the two parameters by 0.1.
The stability picture of each system is signiﬁcantly diﬀerent. In the Base Model, λ5 is
zero for all values of α3 and α4 , while for Model 2, there was some switching between λ2
and λ4 , as seen in the upper left hand corner of the contour plots for these two eigenvalues
in ﬁgure 3.11.
We ran simulations for other reaction rate regimes and found that over a range of values
for α3 and α4 , there was consistent switching of eigenvalues. Figure 3.12 shows Model 2 with
forward rates doubled. Note the switching behavior between λ2 , λ3 , and λ4 .
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Figure 3.11: λi as a function of α3 and α4 .

Figure 3.12: Switching Behavior of λ2 , λ3 and λ4 with forward rates doubled.
Figure 3.12 is a good example of the switching behavior we observed as we varied reaction
rates. Note how λ3 = 0 for low α3 , α4 , and that as we increase these two parameters, λ2 is
zero and then ﬁnally λ4 is zero. This was the case for all rate environments that we ran,
albeit not always as pronounced. Thus, for any rate environment, the stability of the system
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near the point of equilibrium was neutrally stable.

We then ran contour plots varying n and m which are shown below. We ran two cases for
each model: n = 2, m = 4, and n = 8, m = 40. These would represent oligomer sizes both
less than and greater than our standard designation for n and m of 4 and 20 respectively.

Figure 3.13: Switching of eigenvalues in Base Model as n and m are varied. The white region
in both plots indicates a zero value for the eigenvalue for any value of the parameters.
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Figure 3.14: Switching of eigenvalues in Model 2 as n and m are varied.
In the case of the Base Model, there was no switching of eigenvalues for a given species
size environment as α3 and α4 are varied. For the Base Model, λ5 is zero for all values of
α3 and α4 when n = 2 and m = 4, and when n = 8 and m = 40, λ4 is zero. For Model
2, there is switching between λ2 , λ3 , and λ4 when n = 2 and m = 4, whereas when n = 8
and m = 40, there is switching between λ1 , λ2 and λ3 . In general, as with the Four Species
Model, as n and m are increased, the overall magnitude of stability increases.

40

Aβ Protein Aggregation

α4
2
4
8
16
32
64

Switch
α3
0.9
1.525
2.35
4.05
6.65
8.05

Cross
α3
2
4
8
16
32
64

Table 3.6: Switch and cross points of α3 as a function of α4 .
Finally, we then looked to analyze the eﬀect on λ1 and λ2 of varying the bridge variables
α3 and α4 . We observed a pattern of switching and crossing of the eigenvalues as the two
bridge parameters are varied. Below is a graph of where we have set α4 = 2 and 0 ≤ α3 ≤ 4.
Note the switching at α4 = 2 and α3 ≈ 0.9 and crossing at α3 = α4 = 2. The table below
shows switching and crossing points for λ1 and λ2 as α3 and α4 vary.

Figure 3.15: Switching and crossing of λ1 , λ2 as a function of α3 .
As can be seen, there is crossing where α3 = α4 , whereas switching has an exponential
relationship between the two parameters. We ran a regression model of the data and found
that α4 ≈ 2.04 × 1.55α3 modeled the switch points with a r2 = 0.953.

We have found that varying reaction rates and oligomer size aﬀected the stability of
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the model. As with the 4 Species Model, given the non-linear nature and the number of
dimensions, analyzing the stability of the model has proved diﬃcult. We were unable to
employ standard methods such as using phase plots and determining bifurcation points that
are used with two dimensional models. Perhaps our analysis of equilibrium, which has shown
that certain rate regimes result in the model not being able to reach equilibrium, explains the
borderline nature of the stability of the model. Using just linear stability analysis, however,
we have shown that over a range of parameter values the model is neutrally stable.

3.4

Numerical Results

The key parameters in our model are α3 and α4 as they are the bridge variables governing
the reaction between on- and oﬀ-pathway. We therefore wanted to see the eﬀect of varying
both on species formation while holding all other reaction rates constant. Figure 3.16 shows
the species concentrations as a function of time for the Base Model. For the purposes
of this topic, we are showing a shorter time span, our previous discussion of equilibrium
notwithstanding: the essential look of the graph to the naked eye is indistinguishable.

Figure 3.16: Concentration levels of Base Model.
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Figure 3.17: Concentration levels of Base Model with α3 , α4 =10.
The ﬁrst graph in ﬁgure 3.16 shows the solution of the system for the Base Model, and
the second shows the solution of the model with increased α3 and α4 . Under the Base Model
reaction rate regime, the prime and non-prime species are approximately equal, whereas
when we increase the bridge variables we see an outperformance of all prime species as
would be expected.

43

Aβ Protein Aggregation





Figure 3.18: Concentration of B1 and Bn as α3 and α4 are varied.
Figure 3.18 shows the solution with just B1 and Bn as we vary α3 and α4 . Note that as


we increase both α3 and α4 , we get an initial spike in the concentration of B1 before settling


back to equilibrium, whereas Bn exhibited no such initial spike. This reﬂects the fact that


over time, the concentration of B1 is reduced in the forward reaction B1  Bn . Figure 3.19
shows just this part of the system.

Figure 3.19: Progression of Species Concentrations. Over time, the spike in concentration




of B1 is reduced as monomers of that species aggregate into Bn .
We now look at the relationship between α3 and α4 , the bridge rates, and the ratio of
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oﬀ-pathway to on-pathway species concentrations. When we increase both α3 and α4 , we see
a direct increase in the ratio of oﬀ-pathway species to on-pathway species. The relationship
 /B
is linear and can be written as: B1 /B1 = α3 , and Bn /Bn = α4 . Because Bm
m is not

directly governed by the bridge variables, it is slower to react to an increase, but eventually
exhibits what appears to be exponential or power growth at higher values of the bridge
 formation is dependent upon α and
variables. This is most likely due to the fact that Bm
3
 in a greater manner.
α4 , so that increasing both eventually impacts Bm

Figures 3.20 and 3.21 underscore the importance of the bridge variables. If we leave α4
 : their
unchanged and just increase α3 , there is limited ﬂow through from B1 to Bn and Bm

ratios to the non-prime species increase slightly above 1, but cease to grow from there even as
α3 continues to increase. Therefore, the bridge reaction Bn  Bn is critical in the formation
of n and m species. For our model, oligomer to oligomer reactions are more signiﬁcant than
monomer to monomer in terms of overall aggregation.

Figure 3.20: Concentration ratios as λ3 and λ4 vary.

45

Aβ Protein Aggregation

Figure 3.21: Concentration ratios as λ3 varies, with λ4 held constant.
We then wanted to test the model to make sure that we could force any species to outperform by varying the rate constants. Forcing B1 to outperform, for instance, is just a matter
of greatly reducing or shutting oﬀ all the forward reactions, and therefore easily done. For
species further down the reaction “chain”, we are required to increase forward reactions to


get the desired outperformance. In the case of Bm , we were able to get outperformance of
this species in absolute terms by dramatically increasing the forward reaction rates α3 , β2 ,
and α6 (see ﬁgure 3.22). Putting these reaction rates at 5 × 104 we were able to achieve this.
Outperformance by Bm was achieved in a similar manner. Doing this has little physical
relevance, but does demonstrate the ability of the model to force a particular species to
outperform in absolute terms.
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Figure 3.22: By increasing the forward reaction rates in the direction of Bm , we were able


to get Bm to outperform all other species on an absolute basis.

3.4.1

Nash Equilibrium of the Six Species Model

As with the Four Species Model, we wanted to look at our model from a game theoretic
point of view. Below are schematics of the 4 equilibrium states that our model can achieve.

Figure 3.23: The four equilibrium states of the system. Clockwise from top left, the ﬁrst
ﬁgure has all on-pathway species outperforming oﬀ-pathway. The second ﬁgure has all
oﬀ-pathway species outperforming on-pathway, and the remaining two are mixed on-/oﬀpathway.
From top-left, clockwise, the ﬁrst schematic highlighted in red is strictly on-pathway,
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with non-prime species “winning”. The next highlighted in blue is strictly oﬀ-pathway, with
all prime species winning. Yellow and green are a mixture of on/oﬀ-pathway.
Using our Base Model reaction rates, we ran simulations varying α3 and α4 to determine
what values of those parameters would cause the diﬀerent conﬁgurations of species dominance. For the simulation below we varied α3 and α4 between 0 and 2 in increments of .02
which resulted in 10,000 discrete points. Figure 3.25 has 0 ≤ α3 , α4 ≤ 10.

Figure 3.24: Aggregation pathways as a function of α3 and α4 with step size of .02. Colors
correspond to the equilibrium states from Figure 3.22.

Figure 3.25: Aggregation pathways as a function of α3 and α4 . The blue region continues
to “win” as α3 and α4 increase without limit.
For the Base Model, the point (α3 , α4 ) = (1, 1) is critical. At (1, 1), the concentration
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α4 < 1
α4 = 1
α4 > 1

Payoﬀ Matrix
α3 < 1
α3 = 1
On
Mixed
Mixed On=Oﬀ
Mixed
Mixed

α3 > 1
Mixed
Mixed
Oﬀ

Table 3.7: Table of equilibrium states as a function of α3 and α4 .
of on- and oﬀ-pathway species are equal. As we vary α3 and α4 from this point we begin
to see dominance of one species type over another. Notable too is the fact that the boundaries between the diﬀerent equilibrium states are so linear: the line α4 = 1 determines the
switching between on- and oﬀ-pathway dominance of n and m species, and the line α3 = 1
determines the switching between on- and oﬀ-pathway dominance of monomers.
Table 3.7 shows the equilibrium states as a function of α3 and α4 in the form of a payoﬀ
matrix. The Nash Equilibrium, in boldface, is where on-pathway species concentrations are
equal to oﬀ-pathway species concentrations.
Next, we prove that the point α3 = α4 = 1 is the Nash Equilibrium of both the Base
Model and Model 2.
Theorem 1. The Nash Equilibrium of the Base Model and Model 2 occur at the point
α3 = α4 = 1.
Proof. In both the Base Model and Model 2, we set all non-bridge forward rates equal to
each other, and all backward rates equal to each other. We let δ be forward rates and μ be
backward rates, and assume that the system is in equilibrium. We then simultaneously solve
equations (3.7)-(3.12) for zero. Equations (3.11) and (3.12) can be rewritten as
m

δBnn = μBm
m


δBn n = μBm

(3.25)
(3.26)

Substituting these expressions into equations (3.09) and (3.10) and then simplifying, we
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rewrite the original system (3.7)-(3.12) as


nμBn + B1 − nδB1n − α3 B1 = 0




(3.27)



nμBn + α3 B1 − nδB1n − B1 = 0

(3.28)

δB1n + δBn − μBn − α4 Bn = 0

(3.29)



δB1n + α4 Bn − μBn − δBn = 0

(3.30)

m

δBnn − μBm = 0

(3.31)

m


δBn n − μBm
=0

(3.32)

We then solve (3.27) and (3.28) for B1 and ﬁnd that


δB1n − μBn = μBn − δB1n

(3.33)

n

Let δB1n − μBn = μBn − δB1 = γ. If γ = 0, equations (3.27)/(3.28) simplify to α3 B1 =
B1 and α4 Bn = Bn , and therefore equality of oﬀ-pathway and on-pathway species when
α3 = α4 = 1. Assume, on the contrary, that γ = 0, and that w.l.og., γ > 0. If we let
α3 = α4 = δ = 1, this implies that
B1 = B1 + nγ

(3.34)

Bn = Bn + γ

(3.35)

which means that B1 > B1 and Bn > Bn . But γ > 0 and equation (3.33) mean that
δ n
μ B1

> Bn and Bn >

δ n
μ B1 ,



which by transitivity further implies that B1n > B1n . This,

however, contradicts our earlier assertion that B1 > B1 . Thus, γ = 0, and when α3 = α4 = 1,
both models are at Nash Equilibrium with the concentration of oﬀ-pathway species equal to
on-pathway species.
It’s notable that unlike with the Four Species Model, we do not get equality of all species
types with one another at the point α3 = α4 = 1. There is undoubtedly at least one unique
set of parameters that would get equality of all 6 species, but ﬁnding that would be diﬃcult
 , we would need to increase
to say the least. As shown with forcing the outperformance of Bm

forward rates dramatically to get equality of species.
We then ran the same code for Model 2, which is the graph below.
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Figure 3.26: Aggregation pathways as a function of α3 and α4 with backward and forward
rates equal.
Once again, the point (α3 , α4 ) = (1, 1) is critical, however, unlike with the Base Model
case it doesn’t strictly deﬁne outperformance of B1 over B1 and vice versa: we still see
B1 outperform B1 for α3 > 1 and low α4 , and B1 outperform B1 for α3 < 1 and high
α4 . The major diﬀerence is that the Red and Blue regions (strictly on-pathway and strictly
oﬀ-pathway respectively) increase at the expense of Green and Yellow (Mixed). More importantly, the range of points (α3 , α4 ) over which on-pathway wins, gets bigger when backward
rates are at parity with forward rates. For 0 ≤ α3 < 1, by increasing β1 and β5 we are
eﬀectively shutting oﬀ the B1  B1 bridge towards oﬀ-pathway aggregation, hence the increase in red in the upper left of the graph in 3.26. The reverse happens in the lower right
for 0 ≤ α4 < 1 as we get greater oﬀ-pathway aggregation up to a point. Despite increasing
α3 above 2, however, if we reduce α4 we continue to see a thin band of dominance (see Fig.
3.27) of Bn and Bm over their primes. Once again, this shows that the Bn  Bn bridge
is more critical for oﬀ-pathway aggregation of n and m species than B1  B1 . Figure 3.27
shows the lower right corner of 3.26 with higher values of α3 , showing that if we reduce α4
we still get on-pathway dominance of n and m species even for high α3 . Thus, it is diﬃcult
to force oﬀ-pathway aggregation of n and m species by just forcing over the B1  B1 bridge.
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Figure 3.27: Dominance of on-pathway n and m species for low α4 and high α3 .

Figure 3.28: Species formation by iteration when successively adding one unit of B1 at
 in the Base Model, prime and
each iteration. Note that with the exception of Bm and Bm

non-prime species are right on top of eachother.
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Lastly, we wanted to look at our model in a more dynamic way. We decided to continuously add new B1 to the system and then watch how each model evolved (ﬁgure 3.28). For
both models, the amount of on-pathway and oﬀ-pathway species was virtually equal (for the
 ). Also, the amount of B and B  eventually outstrips
Base Model, Bm does outperform Bm
m
m

all other species, followed by the n species. In the case of Model 2, the outperformance of the
m species takes longer to happen, which is the result of backward rates being much higher
than those for the Base Model. It seems that both models favor the formation of oligomers
over monomers.

3.5

Fluxes and Forces

Based on the system of equations corresponding to the 6-species aggregation model, we
can compute certain thermodynamic quantities such as ﬂuxes, forces and entropy production
for the diﬀerent pathways that we have identiﬁed. The pathways (Pi , i = 1, 2, 3, 4) are
(−)

equations 3.36-3.39, where P42

refers to the reverse of P42 . The ﬂuxes corresponding to

these pathways is given by Ji = Rif − Rib (i = 1, 2, 3, 4) where Rf refers to the forward
reaction ﬂux and Rb is the backward reaction ﬂux. As a result the individual ﬂuxes are
given by equations 3.40-3.43.

Figure 3.29: A schematic of the reaction pathways.
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On-Pathway P1 = P11 ∪ P12

(3.36)

Oﬀ-Pathway P2 = P21 ∪ P22 ∪ P23

(3.37)
(−)

Oﬀ/On-Pathway P3 = P31 ∪ P32 ∪ P33 ∪ P34 = P21 ∪ P22 ∪ P42 ∪ P12

(3.38)

On/Oﬀ-Pathway P4 = P41 ∪ P42 ∪ P43 = P11 ∪ P42 ∪ P23

(3.39)

J1 = J11 + J12



= (α2 B1n − α1 Bn ) + β3 Bnm/n − α5 Bm

J2 = J21 + J22 + J23


 
 

= α3 B1 − B1 + β2 B1n − β1 Bn + β6 Bnm/n − β5 Bm

(3.40)

(3.41)

J3 = J31 + J32 + J33 + J34 = J21 + J22 − J42 + J12


 
 
 
= α3 B1 − B1 + β2 B1n − β1 Bn + β4 Bn − α4 Bn + β3 Bnm/n − α5 Bm (3.42)
J4 = J41 + J42 + J43 = J11 + J42 + J23


 

= (α2 B1n − α1 Bn ) + α4 Bn − β4 Bn + β6 Bnm/n − β5 Bm

(3.43)

Similarly, the forces corresponding to the diﬀerent pathways can be given by the reaction
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Rif
Rib



.
aﬃnities or forces which can be given by the expression Fi = RT ln




m/n
α2 B1n
β3 Bn
F1 = F11 + F12 = RT ln
+ RT ln
α 1 Bn
α 5 Bm


m/n
α2 β3 B1n Bn
= RT ln
α 1 α 5 Bn Bm






m/n
β2 B1n
β6 Bn
α 3 B1
F2 = F21 + F22 + F23 = RT ln
+ ln
+ ln

B1
β1 Bn
β5 Bm


m/n
α3 β2 β6 B1 B1n Bn
= RT ln

β1 β5 B1 Bn Bm

(3.44)

(3.45)

F3 = F31 + F32 + F33 + F34 = F21 + F22 − F42 + F12








m/n
β2 B1n
α 4 Bn
β3 Bn
α3 B1
+ RT ln
− RT ln
+ RT ln
= RT ln
B1
β1 Bn
β4 Bn
α 5 Bm


m/n
α3 β2 β3 β4 α4 B1 B1n Bn
(3.46)
= RT ln
β1 α4 α5 B1 Bn Bm
F4 = F41 + F42 + F43 = F11 + F42 + F23






m/n
α4 Bn
β6 Bn
α2 B1n
+ RT ln
+ ln
= RT ln

α 1 Bn
β4 Bn
β 5 Bm


m/n
α2 α4 β6 B1n Bn
= RT ln

α1 β4 β5 Bn Bm
The reaction aﬃnities are related to the Gibbs free energy of the system by
−ΔGi = Fi = RT ln Keq

(3.47)

(3.48)

where Keq is the equilibrium constant for the reaction. The Gibbs energy function is also
related to the entropy, S, in the system by
ΔGi = −T ΔS

(3.49)

Therefore, if the change in ΔG is negative (i.e. change in entropy is positive), then the
chemical reaction occurs spontaneously at constant pressure and temperature.

3.6

Entropy Production

The entropy production corresponding to the various pathways is given by
1
σi =
Fik Jik
T
k
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where i = 1, 2, 3, 4. Expanding this sum yields:
1
σ1 =
(3.51)
(F11 J11 + F12 J12 )
T
1
σ2 =
(3.52)
(F21 J21 + F22 J22 + F23 J23 )
T
1
σ3 =
(3.53)
(F31 J31 + F32 J32 + F33 J33 + F34 J43 )
T
1
(3.54)
σ4 =
(F41 J41 + F42 J42 + F43 J43 )
T
where each of the component terms can be obtained from the expressions above. We think
that computing the entropy production rate for each of the pathways can reveal signiﬁcant
information about the underlying energetics of the diﬀerent pathways. To begin with, we
ﬁrst compute the values of σi s at the equilibrium concentrations of the oligomers. The results
are presented in the form of contour plots of σi as a function of the order parameters α3 and
α4 .

Figure 3.30: A contour plot of entropy production along the four diﬀerent pathways as a
function of α3 and α4 . The red regions correspond to large values, while blue points to
smaller values of entropy production. For this calculation, the forward rate constants along
the purely on and oﬀ pathways are taken to be equal to 1.0 while he backward constants are
0.001.
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Chapter 4

Conclusions
4.1

Four Species Model

An important consideration in any numerical simulation such as ours is error. Because
we are dealing with a relatively large, non-linear system it was necessary to use numerical
methods for our solutions. Our choice of numerical solution method was ode45 in Matlab,
which is the Runge-Kutta method of order 4/5. ode45 is considered the method of choice
for non-stiﬀ systems of equations. Stiﬀ equations occur when the solution has a transient
exponential. When this happens, the error term, as represented by the nth derivative, can
get very large in relation to the solution itself [46]. Determining whether a system is stiﬀ in
Matlab is a matter of running the code through ode 45 and seeing if it returns a solution.
If it does, the problem is non-stiﬀ, and if it doesn’t, or run times are exceedingly long, the
problem could potentially be stiﬀ. Our system did not encounter this problem. Nonetheless,
any method employed will involve truncation error. The Runge-Kutta Method of order 4
has local truncation error of O(h4 ). Thus, error related to numerical methods is impossible
to avoid for problems such as ours, and so must be taken into account when considering
whether a model accurately represents the behavior of a physical system. Our limitation
with respect to comparing our results with empirical data makes this an enduring problem
in the study of modeling Aβ aggregation.
Our linear stability analysis of the model showed that the system is stable for a broad
range of parameters. For the Base Case, all eigenvalues were negative indicating asymptotic
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stability. Increasing backward rates relative to forward rates increased the magnitude of
stability as represented by the eigenvalues. λi for i = 1, 2, 3, 4 all became more negative
as backward rates were increased relative to forward rates. We had mixed results when
we increased forward rates. λ1 and λ2 become more negative, but λ3 and λ4 become less
negative. The system is still asymptotically stable, but marginally less so. Varying n also
had mixed results. All eigenvalues become more negative except λ3 which becomes less
negative.
In conclusion, our analysis of linear stability determined that the model was asymptotically stable, with some variation in the magnitude of stability depending on parameter
values.
Equilibrium analysis also revealed some interesting results. The parameter α3 determines
switching between on- and oﬀ-pathway species formation, given that it contains the fatty acid
micelle term L. For α3 < 1 formation of on-pathway species exceeds that of oﬀ-pathway
species, with α3 > 1 leading to an outperformance of oﬀ-pathway species formation. At
α3 = 1, the system is at the Nash Equilibrium where we will have equality of all species over
the long term. While α3 = 1 is the line of demarcation between on- and oﬀ-pathway species
formation, for α3 > 1 we did still see outperformance of Bn over Bn for a period of time. As
α3 approaches 1 from the right, this phenomenon persists for increasingly longer periods of
time. Eventually, however, the concentration of Bn exceeds that of Bn . We were unable to
force a situation where B1 > B1 and Bn < Bn . This is most likely due to the fact that Bn
 is one step removed.
has a direct reaction with B1 whereas Bm

4.2

Six Species Model

Unlike with the Four Species model, we were unable to analytically solve for equilibrium.
We therefore had to use our numerical solutions in determining equilibrium, which were then
veriﬁed with Matlab’s fsolve and found to be within 1% of our values. We found that the time
the system took to achieve equilibrium was very dependent upon the reaction rate regime.
When the ratio of forward to backward rates is close to 1, our model achieves equilibrium
very quickly. When forward rates are considerably higher than backward rates, or vice versa,
the system takes longer to achieve equilibrium due to a cycle of over-shooting of species sizes
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resulting from a large diﬀerence in reaction rates. In the case of high backward rates, the
model didn’t achieve equilibrium at all. Thus, Model 2 achieved equilibrium over a much
shorter time span than the Base Model. The inability of the model to achieve equilibrium
under the conditions of high backward rates is no more than a curiosity as high backward
rates would indicate no aggregation. Increasing n and m resulted in the model taking longer
to achieve equilibrium, which seems to mean that higher exponents increase ﬂuctuations in
the model before it is able to settle down.
In terms of stability, both of the 6 species models we experimented with were neutrally
stable. For all sets of parameter values, there was consistently one eigenvalue with zero real
part, indicating neutral stability: neither do perturbations die out over time nor do they
blow up. This was in contrast to the Four Species model which is asymptotically stable over
a broad range of parameter values. This is possibly a result of the greater complexity of the
Six Species model and the addition of a higher degree oligomer size, m. Further study of
the problem using non-linear methods would be the next step in analyzing stability.
We varied α3 and α4 between 0 − 2, and while we saw switching of stabilities, there was
always at least one eigenvalue with zero real part. Doubled forward rates and varying n and
m saw the same phenomenon: switching of eigenvalues, but neutral stability in all cases.
The greater complexity of the Six Species model yielded very interesting results as we
performed our simulations. As α3 and α4 increase we saw a direct increase in ratio of oﬀpathway to on-pathway species. The relationship is linear and explained by B1 /B1 = α3 ,
and Bn /Bn = α4 . The ratio of m /m is very stable, but when α3 , α4 exceeds 7, it appears
to undergo exponential growth. When we increased only α3 , we saw that there is an initial
increase in the ratio of oﬀ-pathway to on-pathway oligomers, but the curve can be described
as sigmoidal: no matter how high α3 goes, this ratio ceases to grow any higher than 1.
This shows the Bn to Bn bridge is critical for formation of n and m species, and can’t be
forced only over the B1 to B1 bridge. This was conﬁrmed by our examination of the Nash
Equilibrium using Model 2.
We were also able to show that we could get any species to outperform on an absolute
basis. Doing this for n and m species required us to increase forward rates to levels, that
weren’t necessarily realistic, but conﬁrmed the ability of the system to be in any particular
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equilibrium state.
Lastly, dynamic simulations of both models, done by increasing the amount of B1 in the
system at regular intervals, saw both the Base Model and Model 2 favoring the formation of
n and m species. With backward and forward rates equal, Model 2 took longer for this to
happen, but even here, the higher order species eventually dominate. It appears that both
of the models have a preference for oligomers over monomers.

4.3

Future Study

There are a few recommendations for future study. Firstly, analyzing stability with the
use of Lyapunov functions might bear some fruit and help to clear up the stability picture of
the 6 Species models. The number of dimensions of the model and the non-linearity could
mean that another approach to stability analysis is needed. It would be a vindication of the
model to be able to show global stability.
Secondly, analyzing a more dynamical model with increased pathways would be of great
interest. The analysis we have made of the Four and Six Species models has given us a
solid understanding of the behavior of the model. Increasing the number of pathways to
aggregation should be the next step in modeling. Currently, we have just n-mers to n-mers,
but this is almost certainly not the case in vivo, where there can be n-mers to m-mers.
Also, our attempt at a more dynamical model in the Numerical Results section of Chapter
3 was rudimentary: we added discrete amounts of new monomers of B1 in set intervals to
simulate an evolving system. The reality of the process is that the formation of new Aβ
from APP is most likely stochastic. Adding randomness to this part of the model would be
a good addition.
Finally, our look at the thermodynamics of the system in chapter 4 was just the beginning
of what we would like to achieve. This area of our study will be expanded upon in future
work.
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